This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of targeted cancer therapies. It functions as a key component in proteolysis-targeting chimeras (PROTACs), which are designed to degrade specific disease-causing proteins. By facilitating the ubiquitination and subsequent degradation of these proteins, it plays a crucial role in inhibiting cancer cell proliferation and survival. Additionally, its structure is optimized for binding to E3 ubiquitin ligases, making it a valuable tool in the design of novel therapeutic agents for treating various malignancies. Its application extends to research in understanding protein degradation pathways and developing innovative treatments for other protein-related diseases.